Management of Transient Ischemic Attack (TIA)
Patients presenting within 48 hours of TIA with motor weakness, speech disturbance, or other focal neurological symptoms must be immediately sent to an emergency department with advanced stroke care capabilities—this is a medical emergency, not an outpatient problem. 1
Immediate Risk Stratification and Disposition
High-risk patients require immediate ED referral and hospitalization:
- Presentation within 48 hours with unilateral motor weakness (face, arm, or leg), speech/language disturbance, or other focal symptoms mandates immediate ED evaluation 1, 2
- Crescendo TIAs (multiple, increasingly frequent episodes) require immediate hospitalization under all circumstances—never attempt outpatient management 1, 2
- Duration of symptoms >1 hour at presentation requires hospital admission 1
- Symptomatic carotid stenosis >50% requires hospitalization 1
- Known cardiac embolic source (atrial fibrillation) mandates admission 1
- Known hypercoagulable state requires hospitalization 1
The stroke recurrence risk is 1.5% at 2 days and 2.1% at 7 days with modern care, but historically reached 10% in the first week, with approximately half occurring within the first 48 hours 1, 2. Rapid assessment and immediate treatment reduces 90-day stroke risk by 80%, from historical rates of 10-20% down to 2-3% 1.
Time-Critical Diagnostic Workup (Within 24 Hours)
All high-risk patients require completion of the following within 24 hours:
Brain Imaging
- CT or MRI of the brain must be completed within 24 hours to exclude hemorrhage, identify acute infarction, and rule out stroke mimics 3, 2
- MRI with diffusion-weighted imaging (DWI) is preferred over CT when available, as it detects silent cerebral infarctions in up to 31% of TIA patients, identifying highest-risk individuals 1
Vascular Imaging
- CT angiography from aortic arch to vertex should be performed immediately, ideally at the time of initial brain CT, to assess both extracranial and intracranial circulation 2
- Carotid Doppler ultrasound for anterior circulation symptoms must be completed within 24 hours 3, 1
- Transcranial Doppler provides complementary information on cerebral vessel patency, recanalization, and collateral pathways 3
Cardiac Evaluation
- 12-lead ECG must be completed immediately upon arrival to identify atrial fibrillation or other cardioembolic sources 3, 2
- Rhythm monitoring and echocardiography as indicated should be performed within 24 hours 3, 1
Laboratory Studies
- Basic laboratory work including CBC, electrolytes, creatinine, fasting glucose, and lipid panel 3, 1
Immediate Medical Treatment
Antiplatelet Therapy for Non-Cardioembolic TIA
Antiplatelet therapy must be started immediately upon diagnosis for non-cardioembolic TIA 1. The evidence supports:
- Aspirin plus extended-release dipyridamole is more effective than aspirin alone and represents a reasonable first-choice option 4
- Clopidogrel is more effective than aspirin alone and should be used in high-risk patients 4
- Dual antiplatelet therapy (aspirin plus clopidogrel) for a short duration may be considered in the acute phase 1
Anticoagulation for Cardioembolic TIA
For patients with cardioembolic TIA (atrial fibrillation), oral anticoagulation must be initiated with a target INR of 2.5 (range 2.0-3.0) for warfarin, or direct oral anticoagulants as appropriate 5, 6
Urgent Revascularization
Carotid endarterectomy should be performed urgently (ideally within 2 weeks) for symptomatic carotid stenosis >70%, as this reduces stroke risk significantly 1, 5. Even symptomatic stenosis >50% warrants consideration for urgent revascularization 1.
Rapid-Access TIA Clinic Alternative
If immediate ED referral is not feasible for lower-risk patients, a certified rapid-access TIA clinic can evaluate patients within 24-48 hours with immediate access to neuroimaging, vascular imaging, and stroke specialists 1, 2. However, this option is only appropriate for patients who do not meet high-risk criteria listed above 1.
Patients not admitted to the hospital must have rapid access (within 12 hours) for urgent assessment and investigation 3. If cross-sectional imaging, EKG, and carotid ultrasound are performed in the ED and are negative, assessment within 24-48 hours is acceptable, with up to 7 days being appropriate in select cases 3.
Aggressive Risk Factor Modification
All patients require immediate initiation of:
- Statin therapy for cholesterol management, as treatment of high cholesterol is even more important in secondary stroke prevention than in primary prevention 4
- Antihypertensive therapy for blood pressure control, as arterial hypertension management is critical in secondary stroke prevention 4
- Diabetes management with tight glycemic control 1
- Lifestyle modifications including smoking cessation, healthy diet, and regular exercise 6
Critical Pitfalls to Avoid
- Never discharge patients with crescendo TIAs under any circumstances—they mandate immediate hospitalization 1, 2
- Do not delay referral for patients presenting within 48 hours with motor or speech symptoms 1
- Do not attempt outpatient workup for patients with known high-risk features (symptomatic carotid stenosis >50%, atrial fibrillation, hypercoagulable state) 1
- Do not rely solely on ABCD2 scores for disposition decisions—they supplement but do not replace comprehensive evaluation and clinical judgment 2
- Do not delay carotid imaging in anterior circulation TIAs, as urgent revascularization may be needed 2
- Never discharge without confirming outpatient follow-up arrangements and ensuring patients understand the need to return immediately if symptoms recur 1, 2
Local Protocol Development
Hospitals and referring physicians should develop local written protocols that specify:
- Categories of patients who require hospital admission versus rapid-access TIA clinic referral 3
- Indications for initial screening investigations (brain imaging, vascular imaging, cardiac assessment, blood tests) 3
- Indications for specialized investigations (angiography, transesophageal echocardiography, specialized blood tests) 3
- Clear pathways for same-day access to imaging (CT/CTA, MR/MRA, ultrasound) 3